| Literature DB >> 31433987 |
Carles Solà-Riera1, Shawon Gupta2, Kimia T Maleki1, Patricia González-Rodriguez3, Dalel Saidi3, Christine L Zimmer1, Sindhu Vangeti4, Laura Rivino5, Yee-Sin Leo6, David Chien Lye6, Paul A MacAry7, Clas Ahlm8, Anna Smed-Sörensen4, Bertrand Joseph3, Niklas K Björkström1, Hans-Gustaf Ljunggren1, Jonas Klingström9.
Abstract
Cytotoxic lymphocytes normally kill virus-infected cells by apoptosis induction. Cytotoxic granule-dependent apoptosis induction engages the intrinsic apoptosis pathway, whereas death receptor (DR)-dependent apoptosis triggers the extrinsic apoptosis pathway. Hantaviruses, single-stranded RNA viruses of the order Bunyavirales, induce strong cytotoxic lymphocyte responses in infected humans. Cytotoxic lymphocytes, however, are largely incapable of eradicating hantavirus-infected cells. Here, we show that the prototypic hantavirus, Hantaan virus (HTNV), induces TRAIL production but strongly inhibits TRAIL-mediated extrinsic apoptosis induction in infected cells by downregulating DR5 cell surface expression. Mechanistic analyses revealed that HTNV triggers both 26S proteasome-dependent degradation of DR5 through direct ubiquitination of DR5 and hampers DR5 transport to the cell surface. These results corroborate earlier findings, demonstrating that hantavirus also inhibits cytotoxic cell granule-dependent apoptosis induction. Together, these findings show that HTNV counteracts intrinsic and extrinsic apoptosis induction pathways, providing a defense mechanism utilized by hantaviruses to inhibit cytotoxic cell-mediated eradication of infected cells.Entities:
Keywords: MG132; RNA virus; TRAIL; apoptosis; death receptor 5; dengue virus; hantavirus; influenza; orthohantavirus; ubiquitin
Mesh:
Substances:
Year: 2019 PMID: 31433987 DOI: 10.1016/j.celrep.2019.07.066
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423